Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash from Financing
$-2,401 Mil (TTM As of Sep. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2014, Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back shares than it received from issuing new shares. It spent $108 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $294 Mil paying cash dividends to shareholders. It received $73 Mil on other financial activities. In all, Teva Pharmaceutical Industries Ltd spent $329 Mil on financial activities for the three months ended in Sep. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Teva Pharmaceutical Industries Ltd's Cash from Financing for the fiscal year that ended in Dec. 2013 is calculated as:

Cash from Financing(A: Dec. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-497+-2411+0+-1089+114
=-3,883

Teva Pharmaceutical Industries Ltd's Cash from Financing for the quarter that ended in Sep. 2014 is

Teva Pharmaceutical Industries Ltd Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2014 was -619 (Dec. 2013 ) + -634 (Mar. 2014 ) + -819 (Jun. 2014 ) + -329 (Sep. 2014 ) = $-2,401 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Teva Pharmaceutical Industries Ltd's net issuance of stock for the three months ended in Sep. 2014 was $0 Mil. Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Teva Pharmaceutical Industries Ltd's net issuance of debt for the three months ended in Sep. 2014 was $-108 Mil. Teva Pharmaceutical Industries Ltd spent $108 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Teva Pharmaceutical Industries Ltd's net issuance of preferred for the three months ended in Sep. 2014 was $0 Mil. Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Teva Pharmaceutical Industries Ltd's cash flow for dividends for the three months ended in Sep. 2014 was $-294 Mil. Teva Pharmaceutical Industries Ltd spent $294 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Teva Pharmaceutical Industries Ltd's other financing for the three months ended in Sep. 2014 was $73 Mil. Teva Pharmaceutical Industries Ltd received $73 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Net Issuance of Stock -110-246-546000-99-899-1,161-497
Net Issuance of Debt 1,108962,264-1581,678-1,8821,1465,034-3,464-2,411
Net Issuance of Preferred 0000000000
Dividends -121-162-229-299-388-528-668-800-855-1,089
Other Financing -25-143356814519413,802114
Cash from Financing 852-3132,024-3621,358-2,2655733,336-1,678-3,883

Teva Pharmaceutical Industries Ltd Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Net Issuance of Stock -1340-494-200-29700000
Net Issuance of Debt -404-338-2,804-1,782-195-26-4080-1,061-108
Net Issuance of Preferred 0000000000
Dividends -230-237-214-281-268-264-2760-590-294
Other Financing 753,7783123465-63483273
Cash from Financing -761-570266-2,260-748-256-619-634-819-329
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK